Parkinson’s Progress: Insights on Advanced Therapies

Per Odin, Professor at Lund University in Sweden, discusses advanced therapies for Parkinson’s disease. These therapies have been available for nearly 30 years, with various products introduced over time. Notably, new treatments, such as foslevodopa/foscarbidopa subcutaneus L-dopa, is expected to enter the market soon. These new treatments could significantly improve the quality of life for patients with advanced Parkinson’s disease while displaying favorable cost-benefits. Let Per Odin elaborate in this MEDtalk.